-
281
Narrowing the gap between machine learning scoring functions and free energy perturbation using augmented data
Published 2025-02-01“…However, current models lack robust evaluation and fail on tasks encountered in (hit-to-) lead optimisation, such as ranking the binding affinity of a congeneric series of ligands, thereby limiting their application in drug discovery. Here, we address these issues by first introducing a novel attention-based graph neural network model called AEV-PLIG (atomic environment vector–protein ligand interaction graph). …”
Get full text
Article -
282
Phylogeny, Phytomedicines, Phytochemistry, Pharmacological Properties, and Toxicity of Croton gratissimus Burch (Euphorbiaceae)
Published 2022-01-01“…This would give a great indication of discovering new novelties that can give a breakthrough in drug discovery.…”
Get full text
Article -
283
Laser-Based Propagation of Human iPS and ES Cells Generates Reproducible Cultures with Enhanced Differentiation Potential
Published 2012-01-01“…Proper maintenance of stem cells is essential for successful utilization of ESCs/iPSCs as tools in developmental and drug discovery studies and in regenerative medicine. Standardization is critical for all future applications of stem cells and necessary to fully understand their potential. …”
Get full text
Article -
284
Anti-Inflammatory Prostanoids: Focus on the Interactions between Electrophile Signaling and Resolution of Inflammation
Published 2010-01-01“…However, their complex structure results in an inter- and intramolecular selectivity of the residues being modified, thus opening the way for structure-activity and drug discovery studies. Detailed characterization of cyPG interactions with cellular proteins will help us to understand their mechanism of action fully and establish their therapeutic potential in inflammation.…”
Get full text
Article -
285
Therapeutic molecules for multiple human diseases identified from pigeon pea (Cajanus cajan L. Millsp.) through GCâMS and molecular docking
Published 2017-12-01“…Keywords: Breast cancer, Drug discovery, Herbal medicine, In silico, Malaria, Measles, Phyto-compounds, Rheumatoid arthritis, Sickle cell disease, Type II diabetes…”
Get full text
Article -
286
Antidiabetic Activity of Benzopyrone Analogues in Nicotinamide-Streptozotocin Induced Type 2 Diabetes in Rats
Published 2014-01-01“…Benzopyrones are proven antidiabetic drug candidate in diabetic drug discovery. In this view novel synthetic benzopyrone analogues were selected for testing in experimental diabetes. …”
Get full text
Article -
287
Exploiting question-answer framework with multi-GRU to detect adverse drug reaction on social media
Published 2025-02-01“…Abstract Adverse Drug Reactions (ADRs) stand out as a pressing challenge in public health and a critical aspect of drug discovery. The dilemma arises from the inherent impossibility of conducting a comprehensive evaluation of a drug before its market release, constrained by the limitations in scale and duration of clinical trials. …”
Get full text
Article -
288
Antimalarial, Antioxidant, and Toxicological Evaluation of Extracts of Celtis africana, Grosseria vignei, Physalis micrantha, and Stachytarpheta angustifolia
Published 2021-01-01“…The activities of these plants obtained in this study partly give credence to their folkloric use in herbal medicines and suggest that they could provide promising lead compounds for malaria drug discovery programs.…”
Get full text
Article -
289
-
290
hpvPDB: An Online Proteome Reserve for Human Papillomavirus
Published 2013-12-01“…Affluent information in this reserve could be of help for researchers involved in structural virology, cancer research, drug discovery, and vaccine design.…”
Get full text
Article -
291
-
292
Natural Cyclic Peptides: Synthetic Strategies and Biomedical Applications
Published 2025-01-01“…Looking ahead, the future of cyclic peptides in drug discovery is bright. Emerging trends, including integrating computational tools for rational design, novel cyclization techniques to improve pharmacokinetic profiles, and interdisciplinary collaboration among chemists, biologists, and computational scientists, promise to expand the scope of cyclic peptide-based therapeutics. …”
Get full text
Article -
293
A Phage‐Based Approach to Identify Antivirulence Inhibitors of Bacterial Type IV Pili
Published 2025-01-01Get full text
Article -
294
Trends in drug repurposing for chronic hepatitis-B infection: Bibliometric-based approach 1990-2024
Published 2024-01-01“…One of today’s scientific efforts that can accelerate drug discovery for CHB is by using the concept of drug repurposing or drug repositioning. …”
Get full text
Article -
295
Mining the Proteome of subsp. ATCC 25586 for Potential Therapeutics Discovery: An Approach
Published 2016-12-01“…The plethora of genome sequence information of bacteria in recent times has ushered in many novel strategies for antibacterial drug discovery and facilitated medical science to take up the challenge of the increasing resistance of pathogenic bacteria to current antibiotics. …”
Get full text
Article -
296
Modelling hepatocellular carcinoma microenvironment phenotype to evaluate drug efficacy
Published 2025-01-01“…Importantly, we reported for the first time that our model correctly predicted 34 clinical outcomes to TKIs out of 37 case studies on 32 HCC patients confirming that patient-centric spheroids, combined with our TICK exclusion strategy, are valuable models for drug discovery and opening a near perspective to personalized care.…”
Get full text
Article -
297
Effects of atractylodin and β-Eudesmol on P-glycoprotein and Caco-2 cells permeability
Published 2025-02-01Get full text
Article -
298
-
299
Interrelation of Natural Polyphenol and Fibrosis in Diabetic Nephropathy
Published 2024-12-01“…Nowadays, natural polyphenolic compounds with excellent safety and efficacy are playing an increasingly important role in drug discovery. Therefore, this review reveals the multiple mechanisms associated with fibrosis in DN, as well as the different signaling pathways (including TGF-β/SMAD, mTORC1/p70S6K, JAK/STAT/SOCS and Wnt/β-catenin) and the potential role in the fibrotic niche. …”
Get full text
Article -
300
Structure of the Pseudomonas aeruginosa PAO1 Type IV pilus.
Published 2024-12-01“…While Type IV pilus (T4P) structures from other organisms have been previously solved, a high-resolution structure of the native, fully assembled T4P of Pseudomonas aeruginosa, a major human pathogen, would be valuable in a drug discovery context. Here, we report a 3.2 Å-resolution structure of the P. aeruginosa PAO1 T4P determined by electron cryomicroscopy (cryo-EM). …”
Get full text
Article